165 related articles for article (PubMed ID: 24021903)
41. Survival of Burkitt's lymphoma patients in Ghana.
Wosornu JL; Nkrumah FK; Perkins IV
Br J Cancer; 1971 Sep; 25(3):479-86. PubMed ID: 5144522
[TBL] [Abstract][Full Text] [Related]
42. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
43. Treatment of Burkitt's lymphoma: the African experience.
Olweny CL; Nkrumah FK
IARC Sci Publ; 1985; (60):375-82. PubMed ID: 4065949
[TBL] [Abstract][Full Text] [Related]
44. Burkitt's lymphoma--a study of 50 consecutive cases.
Ahmed M; Khan AH; Mansoor A; Khan MA; Saeed S
J Pak Med Assoc; 1993 Aug; 43(8):151-3. PubMed ID: 8264092
[TBL] [Abstract][Full Text] [Related]
45. Burkitt's lymphoma in Europe.
Philip T
IARC Sci Publ; 1985; (60):107-18. PubMed ID: 2998984
[TBL] [Abstract][Full Text] [Related]
46. Clinical characteristics of Burkitt's lymphoma from three regions in Kenya.
Mwanda WO; Orem J; Remick SC; Rochford R; Whalen C; Wilson ML
East Afr Med J; 2005 Sep; 82(9 Suppl):S135-43. PubMed ID: 16619689
[TBL] [Abstract][Full Text] [Related]
47. Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie Pédiatrique.
Bouda GC; Traoré F; Couitchere L; Raquin MA; Guedenon KM; Pondy A; Moreira C; Rakotomahefa M; Harif M; Patte C
J Glob Oncol; 2019 Nov; 5():1-9. PubMed ID: 31794283
[TBL] [Abstract][Full Text] [Related]
48. Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
Adde M; Shad A; Venzon D; Arndt C; Gootenberg J; Neely J; Nieder M; Owen W; Seibel N; Wilson W; Horak ID; Magrath I
Semin Oncol; 1998 Apr; 25(2 Suppl 4):33-9; discussion 45-8. PubMed ID: 9578060
[TBL] [Abstract][Full Text] [Related]
49. [Burkitt lymphoma. Study of 110 patients].
Oji C; Ike I
Mund Kiefer Gesichtschir; 1999 Jul; 3(4):220-4. PubMed ID: 10474269
[TBL] [Abstract][Full Text] [Related]
50. Burkitt's lymphoma in Jordanian children: epidemiological and clinical study.
Madanat FF; Amr SS; Tarawneh MS; el-Khateeb MS; Marar B
J Trop Med Hyg; 1986 Aug; 89(4):189-91. PubMed ID: 3783812
[TBL] [Abstract][Full Text] [Related]
51. Burkitt's lymphoma in adults: a retrospective study of 46 cases.
Ostronoff M; Soussain C; Zambon E; Ibrahim A; Bosq J; Bayle C; Pico JL; Gilles E; Moran A; Droz JP
Nouv Rev Fr Hematol (1978); 1992; 34(5):389-97. PubMed ID: 1296192
[TBL] [Abstract][Full Text] [Related]
52. Factors determining the outcome of management of patients with Burkitt's lymphoma at the University College Hospital Ibadan, Nigeria--an eleven year review.
Fasola FA; Shokunbi WA; Falade AG
Niger Postgrad Med J; 2002 Sep; 9(3):108-12. PubMed ID: 12501276
[TBL] [Abstract][Full Text] [Related]
53. Burkitt's lymphoma/leukemia: a clinicopathologic study on 24 adult patients.
Bernasconi C; Brusamolino E; Pagnucco G; Bernasconi P; Orlandi E; Lazzarino M
Leukemia; 1991; 5 Suppl 1():90-4. PubMed ID: 1890873
[TBL] [Abstract][Full Text] [Related]
54. [Chemotherapy of nonendemic Burkitt's lymphoma].
Kath R; Höffken K; Günzel K; Nowrousian MR; Donhuijsen K; Anders CU; Sack H; Schmidt CG
Dtsch Med Wochenschr; 1990 Aug; 115(33):1219-26. PubMed ID: 2387214
[TBL] [Abstract][Full Text] [Related]
55. Burkitt's lymphoma in Iraq. Clinical and pathological study of forty-seven patients.
Al-Attar A; Al-Mondhiry H; Al-Bahrani Z; Al-Saleem T
Int J Cancer; 1979 Jan; 23(1):14-7. PubMed ID: 215559
[TBL] [Abstract][Full Text] [Related]
56. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
Ribera JM; García O; Grande C; Esteve J; Oriol A; Bergua J; González-Campos J; Vall-Llovera F; Tormo M; Hernández-Rivas JM; García D; Brunet S; Alonso N; Barba P; Miralles P; Llorente A; Montesinos P; Moreno MJ; Hernández-Rivas JÁ; Bernal T
Cancer; 2013 May; 119(9):1660-8. PubMed ID: 23361927
[TBL] [Abstract][Full Text] [Related]
57. Burkitt's lymphoma of the head and neck region in a Nigerian tertiary hospital.
Amusa YB; Adediran IA; Akinpelu VO; Famurewa OC; Olateju SO; Adegbehingbe BO; Komolafe EO; Faponle AF; Olasode BJ
West Afr J Med; 2005; 24(2):139-42. PubMed ID: 16092315
[TBL] [Abstract][Full Text] [Related]
58. Survival of children with endemic Burkitt lymphoma in a prospective clinical care project in Uganda.
McGoldrick SM; Mutyaba I; Adams SV; Larsen A; Krantz EM; Namirembe C; Mooka P; Nabakooza S; Ndagire M; Mubiru K; Nabwana M; Nankinga R; Gerdts S; Gordon-Maclean C; Geriga F; Omoding A; Sessle E; Kambugu J; Uldrick TS; Orem J; Casper C
Pediatr Blood Cancer; 2019 Sep; 66(9):e27813. PubMed ID: 31157502
[TBL] [Abstract][Full Text] [Related]
59. Primary bilateral ovarian Burkitt's lymphoma in a six-year-old child: report of a rare malignancy.
Mondal SK; Bera H; Mondal S; Samanta TK
J Cancer Res Ther; 2014; 10(3):755-7. PubMed ID: 25313777
[TBL] [Abstract][Full Text] [Related]
60. Age and sex as factors influencing remission duration in African Burkitt's lymphoma.
Biggar RJ; Gail MH; Banks RB; Neequaye J; Nkrumah FK
Am J Epidemiol; 1982 Oct; 116(4):668-77. PubMed ID: 7137153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
